Zhuzhou Hezhong Technology Development C

Zhuzhou Hezhong Technology Development C

You are here: HomeProductsCJC-1295 DAC (Drug Affinity Complex)

Contact us

  • Company Name: Zhuzhou Hezhong Technology Development C
  • Country/region: China
  • Contact Person: Ms.dan Amy
  • Tel: 86-0731-22290203
  • Email:

CJC-1295 DAC (Drug Affinity Complex)

    Detailed Description

    CJC-1295 DAC (Drug Affinity Complex)

    Alias: CJC1295(GHRH/DAC)
    Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-LysLys(Maleimidopropionyl)-NH2 (Drug Affinity Complex)
    CAS: 863288-34-0
    Molecular formula: C165H269N47O46
    Molecular Mass: 3647.15
    Molecular Structure:


    CJC-1295 DAC vs. CJC-1295 No DAC
    CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Growth Hormone Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse of Human Growth Hormone.
    gck16 (at) yccreate dot com
    www dot vit-amino dot com
  • CJC-1295 DAC (Drug Affinity Complex)
  • CJC-1295 DAC (Drug Affinity Complex)